A carregar...
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Major depressive disorder (MDD) is associated with a significant burden and costs to the society. As remission of depressive symptoms is achieved in only one-third of the MDD patients after the first antidepressant trial, unsuccessful treatments contribute largely to the observed suffering and socia...
Na minha lista:
| Publicado no: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761633/ https://ncbi.nlm.nih.gov/pubmed/26467411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150630173522 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|